Biobank

What Biobank does

Biobank is an entity operating a website at biobank.no, a Norwegian top-level domain (.no). The company's name — 'Biobank' — is suggestive of biological sample banking, biorepository services, or a related life-sciences storage/management operation, though the source data contains no explicit product, service, or operational disclosures to confirm the business function. The sole observable public artifact is a website that returns only a loading/verification page with the message 'One moment, please... Please wait while your request is being verified...,' indicating either an active verification challenge, a Cloudflare-style anti-bot interstitial, or a minimal/unfinished public web presence. No information on company type, legal entity structure, founding date, ownership, management team, products, customers, revenue model, technology stack, partnerships, certifications, or geographic scope is available.

No analytical conclusions can be drawn about the company's business model, market position, technology, pricing mechanics, go-to-market motion, customer segments, or competitive landscape. The biobank.no domain and Norwegian locale suggest the entity is domiciled in or primarily associated with Norway, though no formal legal entity confirmation, registry record, or organizational disclosure is present in the source. The absence of public web content means the company may be operating in a non-public-facing mode, may be at an extremely early or dormant stage, or the data collection may have failed to capture substantive pages. Source attribution:.

Given the complete absence of substantive operational information, this profile should be treated as a data-gap case rather than an assessment of the underlying business. No revenue, headcount, funding, product, customer, or technology inferences are defensible from the available source material; any conclusions drawn beyond the naming convention and Norwegian domain inference would constitute fabrication.

Name

Biobank

Website

https://biobank.no

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

1–10 employees

Short description

Biobank operates a website at biobank.no under a Norwegian top-level domain, with a name suggestive of biological sample banking or biorepository services. No products, services, customers, management, funding, or revenue information are publicly disclosed in the available source data.

Ownership category

akta.pro rank

Product category

Biobanking Services

NAICS

Blood and Organ Banks (621991), Medical Laboratories (621511)

SIC

Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Cell & Tissue Banking (biobanking, cord blood/tissue) (HLAAAGAE)

akta.pro secondary industries

Biobank & Biospecimen Management LIMS (HLACAMAG), Sample Collection, Stabilization & Pre-Analytics (biobanking, transport media, extraction kits) (HLAAALAM), Medical & Clinical Specimen Frozen Storage (Labs, Biobanks) (TLALACAE)

Keywords

• Biological sample storage
• Biobanking services
• Biospecimen storage
• Biological repository
• Sample management

Headquarters

HQ city

Hamarvik

HQ country

Norway

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Services

Core offering

Based on the company name "Biobank" and Norwegian domain (biobank.no), the entity is likely engaged in the storage and management of biological samples, but no specific products, services, or operational details are disclosed in the source content, which consists solely of a website loading/verification page.

Differentiator

Problem solved

Functional benefit

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Regional players

• deCODE Genetics (Amgen): deCODE operates a population-scale human biobank in Iceland focused on genomic and disease research; comparable as a Nordic-region biobank leveraging national-scale sample collections for research partnerships.

Direct peers

• Cureline: Cureline is a clinical biobank operator providing human biospecimen collection, processing, and storage for pharmaceutical and diagnostic clients — a closely analogous model to a biobank serving research customers.
• Azenta Life Sciences (formerly Brooks Life Sciences): Azenta operates a global commercial biobanking, sample management, and cold-chain storage business, directly comparable to a biobank operator offering specimen storage and chain-of-custody services.
• Indivumed (a CG Pharmaceuticals company): Indivumed operates a clinical biobank focused on cancer biospecimens and associated multi-omics data — directly comparable to a biobank-as-a-service commercial operator.
• BioServe (a REPROCELL brand): BioServe offers biorepository and biospecimen services for genomic and clinical research, closely mirroring the storage-and-distribution model of a commercial biobank.

Broad incumbents

• Lonza Cell & Gene: Lonza offers cell banking services (MCB/WCB) and broader biomanufacturing infrastructure, overlapping with biobanking activities at a larger, more diversified scale.
• Thermo Fisher Scientific (Biobanking & Storage): Thermo Fisher provides biobanking equipment, consumables, and sample-management software widely used by biobanks, making it an adjacent incumbent serving the same end market.

Market position

Strengths2 records

Weaknesses3 records

Key risks2 records

Key highlights2 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biobank